Dupilumab reduces systemic corticosteroid use and sinonasal surgery rate in CRSwNP

Chronic rhinosinusitis with nasal polyps (CRSwNP) is a type 2 inflammatory disease with a high symptom burden and poor quality of life. Treatment options include recurrent surgeries and/or frequent systemic corticosteroids (SCS). Dupilumab, a fully human monoclonal antibody, blocks the shared recept...

Celý popis

Podrobná bibliografia

Vydané v:	Rhinology Ročník 59; číslo 3; s. 301
Hlavní autori:	Desrosiers, M, Mannent, L P, Amin, N, Canonica, G W, Hellings, P W, Gevaert, P, Mullol, J, Lee, S E, Fujieda, S, Han, J K, Hopkins, C, Fokkens, W, Jankowski, R, Cho, S H, Mao, X, Zhang, M, Rice, M S, Khan, A H, Kamat, S, Patel, N, Graham, N M H, Ruddy, M, Bachert, C
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Netherlands 01.01.2021
Predmet:	Adrenal Cortex Hormones Adult Antibodies, Monoclonal, Humanized Chronic Disease Double-Blind Method Humans Interleukin-13 Nasal Polyps - drug therapy Nasal Polyps - surgery Quality of Life Rhinitis - complications Rhinitis - drug therapy Rhinitis - surgery Treatment Outcome
ISSN:	0300-0729
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!